Global Enteral Nutrition Market Size, Share, Growth, Overview Report, Forecast 2022-2028

Enteral Nutrition Market Size And Industry Analysis

The global enteral nutrition market size was worth USD 3,521.80 million in 2021 and is estimated to grow to USD 6,070.84 million by 2028, with a compound annual growth rate (CAGR) of approximately 9.50 percent over the forecast period. The report analyzes the enteral nutrition market's drivers, restraints/challenges, and their effect on the demands during the projection period. In addition, the report explores emerging opportunities in the enteral nutrition market.

Request Free Sample

Enteral Nutrition Market: Overview

Enteral nutrition refers to any method of eating that involves the passage of food through the digestive tract to meet an individual's caloric needs. In addition, this may also include a regular diet, the use of liquid or powdered supplements, and tube feeding. There are many different devices and devices available to patients for enteral nutrition. These include tubes, pumps, and other flexible tubes that help facilitate fluid flow directly into the digestive tract. Enteral nutrition is essential for people with diabetes, malnutrition, cancer, digestive disorders, and other complications. Alternatively, enteral nutrition may be provided to patients with nutritional deficiencies. An increase in chronic diseases, such as cancer, stroke, multiple sclerosis, dementia, chronic liver disease, chronic obstructive pulmonary disease (COPD), and diabetes is expected to drive demand for products that help patients with oral absorption problems.

Furthermore, the increase in preterm births is one of the crucial factors driving the demand for enteral formula milk to meet the nutritional needs of infants. In addition, the lack of understanding and awareness of clinical nutrition in the medical and healthcare communities has limited its adoption and development. Technological advancement and product innovation are other factors driving the global enteral nutrition market growth.

COVID-19 Impact:

Demand for enteral nutrition products has increased significantly during the pandemic as nutritional therapy is recommended for patients with COVID-19. Assessing the nutritional status of patients with COVID-19 infection is more important. According to data published by the American Society for Parenteral and Enteral Nutrition (ASPEN), all existing guidelines and recommendations for clinical nutrition in critically ill patients also apply to critically ill patients with COVID-19.

Key Insights

• As per the analysis shared by our research analyst, the global enteral nutrition market value is expected to grow at a CAGR of 9.50% over the forecast period.
• In terms of revenue, the global enteral nutrition market size was valued at USD 3,521.80 million in 2021 and is estimated to grow to USD 6,070.84 million by 2028.
• An increase in chronic diseases is expected to drive demand for enteral nutrition products that help patients with oral absorption problems.
• By protein composition, the standard protein diet segment dominated with accounted significant market share in 2021.
• By distribution channel, the hospital sales segment accounted significant amount of market share in 2021.
• In 2021, North America captured the largest revenue share of the global market.

Global Enteral Nutrition Market: Report Scope:

To know more about this report, request a sample copy.

Enteral Nutrition Market: Growth Drivers

The rising investment in R&D aids the global market growth

Factors such as investment in research and development of new medical nutrition products targeting different health conditions and funding by other companies operating in the nutrition industry are expected to drive the growth of the global enteral nutrition market throughout the forecast period. For example, in May 2020, Danone's health nutrition arm, Nutricia, awarded USD 1.1 million to the Global Nutrition Research Program, a research project led by clinicians initiated in 16 countries around the world to define nutritional care guidelines for COVID-19 patients recovering from intensive care (ICU) admission.

Enteral Nutrition Market: Restraints

The lack of understanding may hamper the global market growth

The lack of understanding and awareness of clinical nutrition in the medical and healthcare communities has limited the adoption and development of enteral nutrition. In addition, clinical nutrition requires higher prescription and supervision by medical professionals, which further limits the market's growth. In addition, although these products are gaining more and more acceptance, they are still not fully understood by doctors, patients, and pharmacists. This is one of the major factors restricting physicians from prescribing, recommending, or adopting clinical nutrition, thus holding back the market's growth.

Enteral Nutrition Market: Opportunities

The promising product portfolio brings up several growth opportunities

Technological advancement and product innovation are some of the other factors driving the enteral nutrition market growth. The diversified product portfolio and strong product development offered by the leading players in the market positively impact the growth of the market. Ready-to-use (RTD) and ready-to-use nutritional supplements, tube feeding, and tube feeding for specific indications are some product categories that have gained traction in recent years.

For example, PulmoCare, offered by Abbott, is a dietary supplement for people with COPD. In addition, introducing more and more new products is a significant factor positively influencing the growth of the tube feeding sector. For instance, in 2020, Victus, Inc. announced the launch of ABINTRA Care, specialized nutrition that can support the immune system. This will help the company grow its product portfolio in the specialty nutrition segment.

Enteral Nutrition Market: Segmentation

The global enteral nutrition market is segregated based on protein composition, form, age group, distribution channel, and region.

By protein composition, the market is bifurcated into high protein supplements, standard protein diets, protein for diabetes care patients, and others. Among these, standard protein diets dominate the global enteral nutrition market in 2021 and are expected to continue this trend during the forecast period. Key factors include adopting a wide variety of standard protein diets as it is one of the most appropriate preparations prescribed for patients with diabetes, cancer, and other medical conditions in which they find it difficult to eat solid food. The launch of various protein-rich standard products to meet market demand.

The distribution channel bifurcates the market into hospital sales, retail, and online. The hospital sales segment accounted for the maximum revenue in the market in 2021 and is expected to dominate in the coming years. This is due to the hospital's more significant number of inpatients and outpatients. The hospital sales segment is also expected to grow due to increased patient preference for hospitals.

Recent Developments

• October 2020 - Nestlé Health Science has launched China's first ready-to-drink protein-based fusion food for malnourished people. 
• June 2020- Otuska Pharmaceutical Factory Inc. launched Enoras Liquid, an enteral macromolecular nutrition product.

Regional Landscape

The increasing prevalence of BPH helps North America dominate the global market

North America dominated the global enteral nutrition market and accounts for the largest revenue share of 32% in 2021 due to the growing burden of chronic diseases such as diabetes, cancer, and other neurological diseases. In addition, the growing preference for at-home enteral therapy has reduced the number of patients visiting hospitals and clinics. In addition, increasing malnutrition is expected to drive further demand for enteral nutrition in this region.

Additionally, in the Asia Pacific, the market is expected to show attractive growth over the forecast period. The increasing rate of preterm births is one of the key factors driving demand in the region. According to the World Health Organization (WHO), India, China, Nigeria, Pakistan, and Indonesia are among the five countries with the highest number of premature births. Factors such as increased spending on healthcare and recent improvement of healthcare infrastructure in many countries, including China, Japan, India, and Singapore, are expected to drive the market in the coming years.

Competitive Landscape

Some of the main competitors dominating the global enteral nutrition market include - B. BRAUN MELSUNGEN AG, ABBOTT LABORATORIES, FRESENIUS KABI AG, DANONE S.A., HORMEL FOODS CORPORATION, GLOBAL HEALTH PRODUCTS, INC., MEIJI HOLDINGS CO., LTD., RECKITT BENCKISER GROUP PLC., NESTLE S.A, and VICTUS, INC.

Request Free Sample

The global enteral nutrition market is segmented as follows:

By Protein Composition

• Standard Protein Diet
• High Protein Supplement
• Protein for Diabetes Care Patient
• Others

By Form

• Powder
• Liquid

By Age Group

• Adults (Above 18)
• Pediatric (Below 18)

By Distribution Channel

• Hospital Sales
• Retail
• Online

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France 
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa